Newron Provides End of Year Corporate Update

Newron to Participate in Upcoming Investor Conferences in November and December

Newron Pharmaceuticals Announces Advisory Board Recommendations and Rett Congress Findings

Newron Pharmaceuticals to Present at European Rett Syndrome Congress and Host Advisory Board Meeting

Newron Pharmaceuticals Supports Rett Syndrome Awareness Month this October

Newron raises CHF 27.0 Million in a private placement of new shares

Newron raises CHF 27.0 Million in a private placement of new shares.

Newron launches a private placement of new shares.

Newron launches a private placement of new shares

Newron reports half-year 2017 results

Pagination